Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Cash flows from operating activities:      
Net loss $ (69,944) $ (59,108)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 12,883 3,892  
Stock-based compensation 9,912 2,217  
Change in fair value of warrant liability   56,576  
Amortization (accretion) of discount on investments 413 406  
Amortization of debt financing cost   4  
Provision for bad debt 419 72 $ 447
Loss on disposal of property and equipment 2    
Foreign exchange (gains) losses on intercompany transactions, net 185    
Net increase (decrease) in accrued interest related to marketable securities 949 (240)  
Net unrealized (gain) loss on marketable securities   (25)  
Net unrealized (gain) loss on equity investment 1,700    
Deferred tax benefit (1,256) (27,921)  
Change in fair value of contingent consideration (114)    
Foreign currency transaction (gain) loss 10    
Changes in operating assets and liabilities:      
Accounts receivable 9,489 (61)  
Inventory (15,506) (2,381)  
Prepaid expenses and other current assets (4,087) (4,276)  
Other assets (210) (30)  
Accounts payable (1,333) (3,856)  
Accrued expenses and other current liabilities (3,391) (5,247)  
Customer deposits 2,980 (1,234)  
Current portion of deferred revenue 721 105  
Change in right of use assets and lease liabilities, net (108) (22)  
Other liabilities 12    
Net cash used in operating activities (56,274) (41,129)  
Cash flows from investing activities:      
Purchases of property and equipment (4,074) (262)  
Proceeds from sale of property and equipment 6    
Purchase of marketable securities   (92,386)  
Proceeds from sales and maturities of marketable securities 98,625 48,241  
Cash paid for acquisitions, net of cash acquired (23) (137,646)  
Net cash provided by (used in) investing activities 94,534 (182,053)  
Cash flows from financing activities:      
Proceeds from reverse recapitalization, net of issuance costs   (1,239)  
Proceeds from the exercise of stock options 900 180  
Proceeds from the exercise of stock warrants   158,308  
Payment of taxes related to net share settlement upon vesting of restricted stock units (158) (54)  
Repayment of term loan (43)    
Net cash provided by financing activities 699 157,195  
Effect of exchange rate changes on cash, cash equivalents and restricted cash (349) 26  
Net increase (decrease) in cash, cash equivalents, and restricted cash 38,610 (65,961)  
Cash, cash equivalents, and restricted cash at beginning of period 68,258 484,137 484,137
Cash, cash equivalents, and restricted cash at end of period 106,868 418,176 68,258
Supplemental disclosures of cash flow information      
Cash and cash equivalents 103,590 416,379 65,017
Restricted cash included in other current assets 2,166 1,021  
Restricted cash included in other noncurrent assets 1,112 776  
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 106,868 418,176 $ 68,258
Supplemental cash flow information:      
Interest paid   73  
Non-cash investing and financing activities:      
Net unrealized (gain) loss on investments (12) (1)  
Exercise of private placement warrants   149,904  
Common Stock issued for acquisitions   159,847  
Additions to right of use assets and lease liabilities 7,784 364  
Purchase of property and equipment included in accounts payable 313 50  
Transfers from property and equipment to inventory 1,721    
Transfers from inventory to property and equipment $ 605    
Receivable for warrants exercised   $ 12,357